<DOC>
	<DOC>NCT00678561</DOC>
	<brief_summary>Study will test effectiveness of an experimental drug applied once or twice daily to two psoriasis plaques. Requires 1 clinic visit each week for 5 weeks.</brief_summary>
	<brief_title>Topical CP-690,550 For Chronic Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Having chronic plaque psoriasis for at least 6 months Able to withdraw all prior psoriasis treatments Must agree to avoid prolonged exposure to the sun and avoid use of tanning booths or other ultraviolet light sources during the study Evidence of active, latent, or inadequately treated infection with Mycobacterium tuberculosis Pregnant or lactating women Unwilling to use appropriate contraceptive methods</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>chronic plaque psoriasis, topical treatment</keyword>
</DOC>